MarketScreener Homepage > Equities > Nyse > John Wiley & Sons, Inc. JW.A

Report

Delayed Nyse - 01/26 04:10:00 pm
46.5	USD		-0.39%

01/25

JOHN WILEY & SONS : Childhood Cancer Survivors Are Not More Likely to Terminate their Pregnancies

01/21

JOHN WILEY & SONS : Study Finds Especially High Rates of Lupus in Certain Racial/Ethnic Groups

01/21

JOHN WILEY & SONS : Does Where Older US Adults Die Affect Their Wellbeing at the End of Life?

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

01/19/2021	01/20/2021	01/21/2021	01/22/2021	01/25/2021	Date
47.56(c)	47.68(c)	48.08(c)	48.59(c)	46.68(c)	Last
176 030	179 402	268 029	271 956	255 606	Volume
-0.46%	+0.25%	+0.84%	+1.06%	-3.93%	Change

More quotes

Financials (USD)

Sales 2021	1 923 M - -
Net income 2021	146 M - -
Net Debt 2021	- - -
P/E ratio 2021	17,9x
Yield 2021	2,93%

Sales 2022	1 966 M - -
Net income 2022	145 M - -
Net Debt 2022	- - -
P/E ratio 2022	17,8x
Yield 2022	3,02%

Capitalization	2 640 M 2 640 M -
Capi. / Sales 2021	1,37x
Capi. / Sales 2022	1,34x
Nbr of Employees	6 900
Free-Float	52,5%

More Financials

Company

John Wiley & Sons, Inc. provides knowledge and knowledge-enabled services in the areas of research, professional practice and education. The Company operates through three segments: Research, Professional Development and Education. Through the Research segment, the Company provides digital and print scientific, technical, medical and scholarly journals, reference works, books, database services and advertising. The...

Sector

Professional Information Services

Calendar

03/04

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of John Wiley & Sons, Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about JOHN WILEY & SONS, INC.

01/25	JOHN WILEY & SONS : Childhood Cancer Survivors Are Not More Likely to Terminate ..	PU
01/21	JOHN WILEY & SONS : Study Finds Especially High Rates of Lupus in Certain Racial..	PU
01/21	JOHN WILEY & SONS : Does Where Older US Adults Die Affect Their Wellbeing at the..	PU
01/21	JOHN WILEY & SONS : The Important Role of Pharmacists for Older Adults' Health	PU
01/21	JOHN WILEY & SONS : Social Influence Matters When It Comes to Following Pandemic..	PU
01/21	JOHN WILEY & SONS : Screening Tool May Help Diagnose Mental Disorders in Early P..	PU
01/15	JOHN WILEY & SONS : European Academy of Allergy and Clinical Immunology Extends ..	PU
01/14	JOHN WILEY & SONS : Esteemed scholars and consultants, and bestselling authors o..	PU
01/14	JOHN WILEY & SONS : Wiley Signs Transitional Open Access Agreement with Iowa Sta..	PU
01/12	JOHN WILEY & SONS : International bestselling author Alexander Osterwalder joins..	PU
01/06	JOHN WILEY & SONS : Does a Mother's Pre-Pregnancy Weight Affect Her Children's F..	PU
01/06	JOHN WILEY & SONS : Skin-to Skin Contact with Fathers May Help Newborns After Ca..	PU
01/06	JOHN WILEY & SONS : Study Reports Patient-Reported Loss of Smell in 86 Percent o..	PU
01/06	JOHN WILEY & SONS : How Effective Are Educational Support Programs for Children ..	PU
01/06	JOHN WILEY & SONS : Study Finds Rising Rates of Food Insecurity Among Older Adul..	PU

More news

News in other languages on JOHN WILEY & SONS, INC.

2020	JOHN WILEY & SONS, INC. : Veröffentlichung des Halbjahresergebnisses
2020	JOHN WILEY & SONS, INC. : publication des résultats semestriels
2020	JOHN WILEY & SONS, INC. : Veröffentlichung des Quartalsergebnisses
2020	JOHN WILEY & SONS, INC. : publication des résultats trimestriels
2020	JOHN WILEY & SONS, INC. : Veröffentlichung des Jahresergebnisses

More news

Provided by Scoopnest.com

Chart JOHN WILEY & SONS, INC.

Duration : Period :

John Wiley & Sons, Inc. Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends JOHN WILEY & SONS, INC.

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	HOLD
Number of Analysts	3
Average target price	52,33 $
Last Close Price	46,68 $
Spread / Highest target	28,5%
Spread / Average Target	12,1%
Spread / Lowest Target	-3,60%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Brian A. Napack	President, Chief Executive Officer & Director
Jesse C. Wiley	Non-Executive Chairman
John Anthony Kritzmacher	Chief Financial Officer & Executive VP-Operations
Aref Matin	Chief Technology Officer & Executive VP
Raymond W. McDaniel	Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

JOHN WILEY & SONS, INC.	2.23%	2 640



S&P GLOBAL INC.	-4.20%	75 772
RELX PLC	4.16%	49 079
THOMSON REUTERS CORPORATION	1.64%	40 416
WOLTERS KLUWER	0.96%	22 168
EQUIFAX INC.	-7.31%	21 744

More Results